Author
M. E. Birnbaum
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2018-2023 · peak 6/yrCo-Author Collaboration Network
10 top collaborators · 25 mutual co-author links17 papers
Recent·Most cited
The T cell receptor sequence influences the likelihood of T cell memory formation
K. A. Lagattuta, A. Nathan, L. Rumker, M. E. Birnbaum, S. Raychaudhuri
The study identifies TCR sequence features that influence T cell memory formation and positive selection across different T cell lineages.
bioRxiv · Jul 20, 2023Immunology
High-density microbioreactor process designed for automated point-of-care manufacturing of CAR T cells
W.-X. Sin, N. S. Jagannathan, D. B. L. Teo, F. Kairi, D. Sandikin, K.-W. Cheung, Y. H. Lee, R. J. Ram, L. Tucker-Kellogg, M. E. Birnbaum
This paper introduces a high-density microbioreactor for automated CAR T cell manufacturing, achieving clinical dose levels in a small footprint with comparable functional attributes to traditional methods.
bioRxiv · Apr 7, 2023Bioengineering
Decoupled neoantigen cross-presentation in tumors with high intratumor heterogeneity reduces dendritic cell activation to limit anti-tumor immunity
K. B. Nguyen, C. J. Copeland, C. M. Backlund, N. G. Klop-Packel, T. Remba, B. Kim, N. K. Singh, M. E. Birnbaum, D. J. Irvine, S. Spranger
This study shows that clonal neoantigen expression enhances dendritic cell activation and anti-tumor immunity, while subclonal expression reduces it in tumors with high intratumor heterogeneity.
bioRxiv · Dec 16, 2022Immunology
Yeast display platform for expression of linear peptide epitopes to assess peptide-MHC-II binding in high-throughput
B. D. Huisman, P. A. Balivada, M. E. Birnbaum
This paper introduces a yeast display platform for high-throughput assessment of peptide-MHC-II binding by decoupling MHC-II expression from peptides.
bioRxiv · Aug 9, 2022Immunology
An unbiased characterization of the HLA-E and CD94/NKG2x peptide repertoire reveals peptide ligands that skew NK cell activation
B. D. Huisman, N. Guan, T. Ruckert, L. Garner, N. K. Singh, A. J. McMichael, G. M. Gillespie, C. Romagnani, M. E. Birnbaum
The paper identifies 500 HLA-E-bound peptides that bind CD94/NKG2A or CD94/NKG2C, revealing ligands that modulate NK cell activation.
bioRxiv · Aug 3, 2022Immunology
Identification of highly cross-reactive mimotopes for a public T cell response in murine melanoma
B. E. Grace, C. M. Backlund, D. M. Morgan, B. H. Kang, N. K. Singh, B. D. Huisman, C. G. Rappazzo, K. D. Moynihan, L. Maiorino, C. S. Dobson, T. Kyung, K. S. Gordon, P. V. Holec, O. C. T. Mbah, D. Garafola, , M. E. Birnbaum
The paper identifies a dominant tumor-associated antigen in murine melanoma and shows that engineered mimotopes can induce cross-reactive T cell responses.
bioRxiv · Feb 28, 2022Immunology
A high-throughput yeast display approach to profile pathogen proteomes for MHC-II binding
B. D. Huisman, Z. Dai, D. K. Gifford, M. E. Birnbaum
The paper presents a high-throughput yeast display method to assess MHC-II binding of peptides from SARS-CoV-2 and dengue virus, identifying binders missed by computational predictions.
bioRxiv · Feb 22, 2022Immunology
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening.
A. Ramos, C. E. Koch, Y. Liu, R. D. Hellinger, T. Kyung, K. L. Abbott, J. Froese, D. Goulet, K. S. Gordon, R. C. Larson, J. G. Doench, A. Regev, M. G. Vander Heiden, M. V. Maus, M. E. Birnbaum, M. Hemann
This study identifies leukemia-intrinsic resistance mechanisms to CAR-T therapy through in vivo CRISPR screening in a murine B-ALL model, revealing IFNγ/JAK/STAT and antigen processing pathways as key mediators.
bioRxiv · Feb 15, 2022 · PreprintCancer Biology
Antigen identification and high-throughput interaction mapping by reprogramming viral entry
C. S. Dobson, A. N. Reich, S. Gaglione, B. E. Smith, E. J. Kim, J. Dong, L. Ronsard, V. Okonkwo, D. Lingwood, M. Dougan, S. K. Dougan, M. E. Birnbaum
This paper introduces RAPTR, a method to identify antigens and map their interactions with immune receptors using viral pseudotyping and single-cell sequencing.
bioRxiv · Sep 18, 2021Immunology
CARPOOL: A library-based platform to rapidly identify next generation chimeric antigen receptors
T. Kyung, K. S. Gordon, C. R. Perez, P. V. Holec, A. Ramos, A. Q. Zhang, Y. Liu, C. Koch, A. Starchenko, B. Joughin, D. A. Lauffenburger, D. J. Irvine, M. T. Hemann, M. E. Birnbaum
The paper develops a library-based platform to identify optimized chimeric antigen receptors (CARs) with improved anti-tumor functions through high-throughput screening of diverse signaling domains.
bioRxiv · Jul 9, 2021Immunology
Extracting and Interpreting the Effects of Higher Order Sequence Features on Peptide MHC Binding
Z. Dai, B. D. Huisman, M. E. Birnbaum, D. K. Gifford
This paper extracts and interprets sequence features affecting peptide MHC binding using yeast display data, showing they accurately predict binding and align with structural knowledge.
bioRxiv · Nov 20, 2020 · PreprintImmunology
Vaccination reshapes the virus-specific T cell repertoire in unexposed adults
Y.-G. Pan, B. Aiamkitsumrit, L. Bartolo, Y. Wang, C. Lavery, A. Marc, P. V. Holec, C. G. Rappazzo, T. Eilola, P. A. Gimotty, S. E. Hensley, R. Antia, V. I. Zarnitsyna, M. E. Birnbaum, L. F. Su
This study examines how pre-existing T cell characteristics influence the immune response to a yellow fever vaccine, finding that memory T cells and rare populations shape post-vaccination responses.
bioRxiv · Oct 1, 2020Immunology
Machine learning optimization of peptides for presentation by class II MHCs
Z. Dai, B. D. Huisman, H. Zeng, B. Carter, S. Jain, M. E. Birnbaum, D. K. Gifford
The paper develops a machine learning method to optimize peptide binding to class II MHCs by modifying anchor residues, validated through a yeast display assay.
bioRxiv · Aug 18, 2020Immunology
Rapid Assessment of T-Cell Receptor Specificity of the Immune Repertoire
X. Lin, J. T. George, N. P. Schafer, K. Ng Chau, M. E. Birnbaum, C. Clementi, J. N. Onuchic, H. Levine
This paper introduces RACER, a pairwise energy model that assesses TCR-peptide affinity using supervised machine learning, demonstrating its utility in simulating thymic selection and estimating recognition rates for tumor antigens.
bioRxiv · Apr 6, 2020Biophysics
Antibody Complementarity Determining Region Design Using High-Capacity Machine Learning
G. Liu, H. Zeng, J. Mueller, B. Carter, Z. Wang, J. Schilz, G. Horny, M. E. Birnbaum, S. Ewert, D. K. Gifford
This paper introduces a machine learning method to design human IgG antibodies with superior target affinity and specificity, using high-throughput data without requiring target structural information.
bioRxiv · Sep 3, 2019Immunology
Longitudinal immunosequencing in healthy people reveals persistent T cell receptors rich in public receptors
N. D. Chu, H. S. Bi, R. O. Emerson, A. M. Sherwood, M. E. Birnbaum, H. S. Robins, E. J. Alm
This study tracks T cell receptor beta diversity in healthy individuals over a year, finding persistent receptors linked to antigen exposure history and stable repertoire features.
bioRxiv · Feb 8, 2018Immunology